Tenshi Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 500.90 Cr
- Paid Up Capital ₹ 443.15 Cr
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 6.00 Cr
- Revenue Growth 6.82%
- Profit Growth -11.93%
- Ebitda -20.66%
- Net Worth -8.35%
- Total Assets 7.29%
About Tenshi Life Sciences
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74110TN2016PTC126537
- Company No.
126537
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 2016
- Date of AGM
31 Dec 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Tenshi Life Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hiranmayi Venkatadri  | Company Secretary | 17-Dec-2018 | Current |
| Venkatadri Hiranmayi | Company Secretary | 17-Dec-2018 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aditya Kumar | Director | 31-Dec-2020 | Current |
| Chandrappa Seetharamaiah | Whole-Time Director | 26-Feb-2021 | Current |
| Tarun Singh | Director | 09-Sep-2020 | Current |
Financial Performance of Tenshi Life Sciences.
Tenshi Life Sciences Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 6.82% increase. The company also saw a substantial fall in profitability, with a 11.93% decrease in profit. The company's net worth dipped by a decrease of 8.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tenshi Life Sciences?
In 2022, Tenshi Life Sciences had a promoter holding of 73.15% and a public holding of 26.85%. The company had 7 Subsidiaries and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Naari Pharma Private LimitedChandrappa Seetharamaiah is a mutual person
Strides Consumer Private LimitedAditya Kumar is a mutual person
Skanray Healthcare Global Private LimitedChandrappa Seetharamaiah is a mutual person
Velbiom Probiotics Private LimitedAditya Kumar is a mutual person
Steribrooks Penems Private LimitedAditya Kumar is a mutual person
- Pronomz Ventures Llp
Chandrappa Seetharamaiah is a mutual person
Charges (Loans)
₹0
₹6.00 Cr
Charges Breakdown by Lending Institutions
- Others : 6.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2020 | Others | ₹6.00 Cr | Satisfied |
How Many Employees Work at Tenshi Life Sciences?
Tenshi Life Sciences has a workforce of 14 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tenshi Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tenshi Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
